Covalon Technologies Ltd.
COV.VTSXVHealthcare● Active
$2.16
+$0.06(+2.86%)
Market Cap$59655046
P/E Ratio—
52W High$3.1
52W Low$1.55
Covalon Technologies Ltd. (COV.V) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
COV.V · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 21, 2026EPS Actual
$0.04
Est. $0.02 · +100.0%
Revenue
$0.01B
Est. $0.01B · -6.3%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 21, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue✓ 1-Quarter EPS Beat Streak
COV.V reports quarterly as a TSXV-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 20, 2026 | $0.02 | — | — | — | $0.01B | — |
| ▲ Q2 FY2026 | May 21, 2026 | $0.02 | $0.04 | +100.0% | $0.01B | $0.01B | -6.3% |
| ▼ Q1 FY2026 | Feb 25, 2026 | $0.04 | $0.00 | -88.5% | $0.01B | $0.01B | -22.9% |
| ▲ Q4 FY2025 | Dec 11, 2025 | -$0.04 | $0.01 | +132.7% | $0.01B | $0.01B | -13.1% |
| ▲ Q3 FY2025 | Aug 21, 2025 | -$0.04 | $0.00 | +105.8% | $0.01B | $0.01B | -20.2% |
| ▲ Q2 FY2025 | May 27, 2025 | $0.01 | $0.02 | +100.0% | $0.01B | $0.01B | -18.8% |
| ▲ Q1 FY2025 | Feb 21, 2025 | -$0.03 | $0.04 | +233.3% | $0.01B | $0.01B | +6.5% |
| ▼ Q1 FY2025 | Jan 7, 2025 | $0.05 | $0.02 | -60.0% | $0.01B | $0.01B | -9.7% |
Q3 FY2026
Aug 20, 2026
EPS Actual
—
EPS Est.
$0.02
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 21, 2026Beat
EPS Actual
$0.04
EPS Est.
$0.02
EPS Surpr.
+100.0%
Revenue
$0.01B
Q1 FY2026
Feb 25, 2026Miss
EPS Actual
$0.00
EPS Est.
$0.04
EPS Surpr.
-88.5%
Revenue
$0.01B
Q4 FY2025
Dec 11, 2025Beat
EPS Actual
$0.01
EPS Est.
-$0.04
EPS Surpr.
+132.7%
Revenue
$0.01B
Q3 FY2025
Aug 21, 2025Beat
EPS Actual
$0.00
EPS Est.
-$0.04
EPS Surpr.
+105.8%
Revenue
$0.01B
Q2 FY2025
May 27, 2025Beat
EPS Actual
$0.02
EPS Est.
$0.01
EPS Surpr.
+100.0%
Revenue
$0.01B
Q1 FY2025
Feb 21, 2025Beat
EPS Actual
$0.04
EPS Est.
-$0.03
EPS Surpr.
+233.3%
Revenue
$0.01B
Q1 FY2025
Jan 7, 2025Miss
EPS Actual
$0.02
EPS Est.
$0.05
EPS Surpr.
-60.0%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2026 | $0.03 | $0.03 | $0.03 | 1 |
| Q2 FY2026 | $0.02 | $0.02 | $0.02 | 1 |
| Q1 FY2026 | $0.02 | $0.02 | $0.02 | 1 |
| Q4 FY2025 | $0.04 | $0.04 | $0.04 | 1 |
| Q3 FY2025 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Q2 FY2025 | $0.04 | $0.04 | $0.04 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 21, 2026 | +100.0% | $2.08 | $2.00 | -3.85% |
| ▼ Q1 FY2026 | Feb 25, 2026 | -88.5% | $1.61 | $1.82 | +13.04% |
| ▲ Q4 FY2025 | Dec 11, 2025 | +132.7% | $1.97 | $1.84 | -6.60% |
| ▲ Q3 FY2025 | Aug 21, 2025 | +105.8% | $2.88 | $2.40 | -16.67% |
| ▲ Q2 FY2025 | May 27, 2025 | +100.0% | $2.65 | $2.80 | +5.66% |
| ▲ Q1 FY2025 | Feb 21, 2025 | +233.3% | $3.18 | $2.80 | -11.95% |
| ▼ Q1 FY2025 | Jan 7, 2025 | -60.0% | $3.59 | $3.29 | -8.36% |
| — Q3 FY2024 | Aug 21, 2024 | — | $2.76 | $3.00 | +8.70% |
Q2 FY2026-3.85%
Report Date
May 21, 2026
EPS Beat/Miss
+100.0%
Price Before
$2.08
Price After
$2.00
Q1 FY2026+13.04%
Report Date
Feb 25, 2026
EPS Beat/Miss
-88.5%
Price Before
$1.61
Price After
$1.82
Q4 FY2025-6.60%
Report Date
Dec 11, 2025
EPS Beat/Miss
+132.7%
Price Before
$1.97
Price After
$1.84
Q3 FY2025-16.67%
Report Date
Aug 21, 2025
EPS Beat/Miss
+105.8%
Price Before
$2.88
Price After
$2.40
Q2 FY2025+5.66%
Report Date
May 27, 2025
EPS Beat/Miss
+100.0%
Price Before
$2.65
Price After
$2.80
Q1 FY2025-11.95%
Report Date
Feb 21, 2025
EPS Beat/Miss
+233.3%
Price Before
$3.18
Price After
$2.80
Q1 FY2025-8.36%
Report Date
Jan 7, 2025
EPS Beat/Miss
-60.0%
Price Before
$3.59
Price After
$3.29
Q3 FY2024+8.70%
Report Date
Aug 21, 2024
EPS Beat/Miss
—
Price Before
$2.76
Price After
$3.00
Avg Beat Reaction-6.68%
Avg Miss Reaction+2.34%
Beat Rate5 / 8 quarters
Largest Move-16.67% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: COV.V ends December
Covalon Technologies Ltd. (COV.V) most recently reported earnings on May 21, 2026 for Q2 FY2026, posting EPS of $0.04 — beating the analyst consensus of $0.02 by +100.0%. The next COV.V earnings date is expected around September 1, 2026.
Each quarter, investors track COV.V earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. COV.V revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
COV.V's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
COV.V earnings · 5 questionsCovalon Technologies Ltd.'s next earnings report is expected around September 1, 2026. COV.V typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; COV.V historically reports after market close (AMC).
COV.V earnings datewhen is COV.V earningsCOV.V next earnings datewhen does COV.V report earningsCOV.V earnings calendar
▸ Source: FMP · Covalon Technologies Ltd. SEC filings · US GAAP · Covalon Technologies Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026